Copyright
©The Author(s) 2022.
World J Clin Cases. Mar 16, 2022; 10(8): 2550-2558
Published online Mar 16, 2022. doi: 10.12998/wjcc.v10.i8.2550
Published online Mar 16, 2022. doi: 10.12998/wjcc.v10.i8.2550
Table 1 Antimicrobial-susceptibility of the isolated strain on May 30th and June 7th
| Antibiotics | MIC (mg/mL) | MIC categories | ||
| Pre-test | Post-test | Pre-test | Post-test | |
| Penicillin G | ≥ 0.5 | ≥ 0.5 | R | R |
| Oxacillin | ≥ 4 | ≥ 4 | R | R |
| Gentamicin | ≤ 0.5 | ≤ 0.5 | S | S |
| Levofloxacin | 0.5 | 0.5 | S | S |
| Erythromycin | ≥ 8 | ≥ 8 | R | R |
| Clindamycin | ≥ 4 | ≥ 4 | R | R |
| Linezolid | 2 | 2 | S | S |
| Teicoplanin | ≤ 0.5 | ≤ 0.5 | S | S |
| Vancomycin | ≤ 0.5 | 1 | S | S |
| Tigecycline | ≤ 0.12 | ≤ 0.12 | S | S |
- Citation: Hong XB, Yu ZL, Fu HB, Cai ZH, Chen J. Daptomycin and linezolid for severe methicillin-resistant Staphylococcus aureus psoas abscess and bacteremia: A case report and review of the literature. World J Clin Cases 2022; 10(8): 2550-2558
- URL: https://www.wjgnet.com/2307-8960/full/v10/i8/2550.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v10.i8.2550